Armistice Capital’s DexCom DXCM Stock Holding History

Armistice Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-323,052	Closed	-$21.4M	–	330
2025 Q4	$21.4M	Buy	+323,052	New	+$20.9M	0.26%	64
2024 Q3	–	Sell	-8,328	Closed	-$944K	–	280
2024 Q2	$944K	Buy	+8,328	New	+$1.05M	0.01%	163
2021 Q3	–	Sell	-232,000	Closed	-$24.8M	–	144
2021 Q2	$24.8M	Sell	232,000 -96,000	-29%	-$9.22M	0.44%	61
2021 Q1	$29.5M	Buy	328,000 +72,000	+28%	+$6.76M	0.68%	43
2020 Q4	$23.7M	Buy	+256,000	New	+$22.9M	0.8%	39

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Armistice Capital's DXCM Position: Q1 2026 in Review

Armistice Capital sold out of DexCom (DXCM) in Q1 2026, closing a stake of 323,052 shares — an estimated $21.4M sold.

Armistice Capital first reported a position in DXCM in Q4 2020 and held it in 5 quarters. The position peaked at $29.5M in Q1 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Armistice Capital reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
Armistice Capital sold 323,052 DexCom shares in Q1 2026, an estimated $21.4M.
Armistice Capital first reported a position in DexCom in Q4 2020 and held it in 5 quarters.
Armistice Capital's DexCom position peaked at $29.5M in Q1 2021.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.